Background Osteoporosis is common in patients with COPD, but its prevalence and
progression are not well characterized. Concerns have been raised over the possible …

Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of
osteoporosis. However, the prevalence, correlates and effectiveness of treatment of …

Background Osteoporosis is prevalent in individuals with COPD. Updated evidence is
required to complement the previous systematic review on this topic to provide best practice …

COPD and osteoporosis are strongly associated because of common risk factors such as
age, smoking, and inactivity. In addition, COPD-related systemic inflammation, vitamin D …

Deleterious effect of oral corticosteroids on bone has been well documented, whereas this
remains debated for inhaled ones (ICS). Our objectives were to analyze the effects of ICS on …

BACKGROUND: Osteoporosis is one of the systemic features of COPD. OBJECTIVE: To
determine the prevalence of osteoporosis in a sample of COPD out-patients, and investigate …

Background It is not certain whether inhaled corticosteroid (ICS) therapy reduces bone
mineral density (BMD) in asthmatic patients. In addition, the potential risk of osteoporosis …

One of the extrapulmonary effects of chronic obstructive pulmonary disease (COPD) is
osteoporosis. Osteoporosis is characterized by a low bone mineral density (BMD) and …

Background It is uncertain whether long-term use of inhaled corticosteroids (ICSs), widely
used to treat COPD, increases the risk of fracture, particularly in women, in view of the …

Currently, our knowledge on the progression of osteoporosis and its determinants is limited
in patients with chronic obstructive pulmonary disease (COPD). Bone mineral density …